Steven Cohen's LEGN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2.78 M shares of Legend Biotech Corporation (LEGN) worth $60.54 M, representing 0.07% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in LEGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 2.78 M shares. Largest reduction occurred in Q2 2021, reducing 1.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Legend Biotech Corporation (LEGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Legend Biotech Corporation (LEGN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.78 M | New Buy | 2.78 M | $21.74 |
| Q3 2025 | -227,906 | Sold Out | 0 | $0.00 |
| Q2 2025 | +227,906 | New Buy | 227,906 | $35.49 |
| Q4 2024 | -195,371 | Sold Out | 0 | $0.00 |
| Q3 2024 | -109,149 | Reduce 35.84% | 195,371 | $48.73 |
| Q2 2024 | +304,520 | New Buy | 304,520 | $44.29 |
| Q4 2022 | -107,000 | Sold Out | 0 | $0.00 |
| Q3 2022 | -105,900 | Reduce 49.74% | 107,000 | $40.80 |
| Q2 2022 | +212,900 | New Buy | 212,900 | $55.00 |
| Q2 2021 | -1.64 M | Sold Out | 0 | $0.00 |
| Q1 2021 | +1.64 M | New Buy | 1.64 M | $29.02 |
Steven Cohen's Legend Biotech Corporation Investment FAQs
Steven Cohen first purchased Legend Biotech Corporation (LEGN) in Q1 2021, acquiring 1,639,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Legend Biotech Corporation (LEGN) for 11 quarters since Q1 2021.
Steven Cohen's largest addition to Legend Biotech Corporation (LEGN) was in Q4 2025, adding 2,784,806 shares worth $60.54 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,784,806 shares of Legend Biotech Corporation (LEGN), valued at approximately $60.54 M.
As of the Q4 2025 filing, Legend Biotech Corporation (LEGN) represents approximately 0.07% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Legend Biotech Corporation (LEGN) was 2,784,806 shares, as reported at the end of Q4 2025.